Gilead licenses hepatitis C drug to Cipla, Ranbaxy, 5 others

Cadila Healthcare, Mylan Laboratories Ltd, Sequent Scientific Ltd, Strides Arcolab Ltd and Hetero Drugs Ltd are the others who will now be able to make and sell the Sovaldi generic, the company said in a statement. The companies will be allowed to set their own prices for the generic drug, and will pay a royalty on their earned sales to Gilead, it said.



via Health News Headlines - Yahoo News http://ift.tt/1sWtoWQ